New Indication: Pralsetinib for advanced RET-mutated thyroid cancer
|New Indication: Pralsetinib for advanced RET-mutated thyroid cancer|
Not published yet (Nov 2020)https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214701s000lbl.pdf
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.